<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Saudi Med</journal-id>
      <journal-id journal-id-type="publisher-id">ASM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Saudi Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0256-4947</issn>
      <issn pub-type="epub">0975-4466</issn>
      <publisher>
        <publisher-name>Medknow Publications</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20427947</article-id>
      <article-id pub-id-type="pmc">2886881</article-id>
      <article-id pub-id-type="publisher-id">ASM-30-245a</article-id>
      <article-id pub-id-type="doi">10.4103/0256-4947.62827</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>RE: Reactive macrophage activation syndrome (MAS) in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedema</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gonzalez-Granado</surname>
            <given-names>Luis</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Correspondence: Valladolid, Spain <email xlink:href="nachgonzalez@gmail.com">nachgonzalez@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2010</year>
      </pub-date>
      <volume>30</volume>
      <issue>3</issue>
      <fpage seq="a">245</fpage>
      <lpage>245</lpage>
      <permissions>
        <copyright-statement>&#xA9; Annals of Saudi Medicine</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> I read with keen interest the article published by Soldo-Juresa et al in the last issue of the journal.<xref ref-type="bibr" rid="CIT1">1</xref> I would like to make some comments: First, Still disease should be kept in mind whenever macrophage activation syndrome is considered in a patient with the clinical picture shown. In fact the patient's condition fulfills the criteria published by Yamagushi for Still disease.<xref ref-type="bibr" rid="CIT2">2</xref> I would like to remark that the measurement of soluble IL-2R (also known as CD25s) could be helpful in distinguishing between Still disease and MAS.<xref ref-type="bibr" rid="CIT3">3</xref> Furthermore, the development of MAS in Still disease is not infrequent and intravenous gamma globulins have shown promising results in treatment.<xref ref-type="bibr" rid="CIT4">4</xref><xref ref-type="bibr" rid="CIT5">5</xref> Second, as the authors rule out a C1q-linked vasculitis, C4 and alternative complement pathway activity should be measured. It is well known that in esterase inhibitor type II levels of C1-inhibitor esterase are normal although C4 is decreased due to low functional C1-inhibitor levels.<xref ref-type="bibr" rid="CIT6">6</xref> Hypocomplementemic vasculitis has been also described in patients with factor I deficiency.<xref ref-type="bibr" rid="CIT7">7</xref> I have attended recently a patient with vasculitis secondary to factor I deficiency. This factor was not measured by the author in this patient. Third, the authors recognize that DNA of parvovirus B-19 can persist in bone marrow for years. This is why we should distinguish between MAS secondary to viral infection or underlying Still disease that needs long-term treatment and follow-up.</p>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="CIT1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soldo-Juresa</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Radman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pejsa</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bozikov</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Reactive macrophage activation syndrome in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedema</article-title>
          <source>Ann Saudi Med</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>88</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">20103968</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsunematsu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kasukawa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kashiwazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Preliminary criteria for classification of adult Stills disease</article-title>
          <source>J Rheumatol</source>
          <year>1992</year>
          <volume>19</volume>
          <fpage>424</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="pmid">1578458</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bleesing</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Prada</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Villanueva</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ilowite</surname>
              <given-names>NT</given-names>
            </name>
            <name>
              <surname>Brunner</surname>
              <given-names>HI</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Sherry</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Passo</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Ramanan</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Filipovich</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grom</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>The diagnostic significance of soluble CD163 and soluble interleukine-2 receptor a -chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis</article-title>
          <source>Arthritis Rheum</source>
          <year>2007</year>
          <volume>56</volume>
          <fpage>965</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">17328073</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garc&#xED;a-Consuegra Molina</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Merino Mu&#xF1;oz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>de Inocencio Arocena</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Grupo de Estudio del S&#xED;ndrome de Activaci&#xF3;n Macrof&#xE1;gica y Artritis Idiop&#xE1;tica Juvenil de la Sociedad Espa&#xF1;ola de Reumatolog&#xED;a Pedi&#xE1;trica. Macrophage activation syndrome and juvenile idiopathic arthritis. A multicenter study</article-title>
          <source>An Pediatr (Barc)</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>110</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">18341875</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vignes</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wechsler</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Amoura</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Papo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Franc&#xE8;s</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Huong</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Veyssier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Godeau</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Piette</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs</article-title>
          <source>Clin Exp Rheumatol</source>
          <year>1998</year>
          <volume>16</volume>
          <fpage>295</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">9631752</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuraw</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Christiansen</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Pathogenesis and laboratory diagnosis of hereditary angioedema</article-title>
          <source>Allergy Asthma Proc</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>487</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">19843402</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadallah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gudat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Laissue</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Spath</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Schifferli</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Glomerulonephritis in a patient with complement factor I deficiency</article-title>
          <source>Am J Kidney Dis</source>
          <year>1999</year>
          <month>6</month>
          <volume>33</volume>
          <issue>6</issue>
          <fpage>1153</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">10352206</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
